Several signaling pathways, such as the PI3K/Akt/mammalian target of rapamycin (mTOR; PAM), Wnt, and RAS/RAF/MEK/ERK pathways, as well as dysregulated p53 signaling, are known to promote and maintain stemness in neuroblastoma. This evidence concerns the gene MTOR and neuroblastoma.